Lukes AS - Search Results

1

A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies.

Al-Hendy A, Lukes AS, Poindexter AN 3rd, Venturella R, Villarroel C, Critchley HO, Li Y, McKain L, Arjona Ferreira JC, Langenberg AG, Wagman RB, Stewart EA. Al-Hendy A, et al. Among authors: lukes as. Pain Manag. 2023 Apr;13(4):205-211. doi: 10.2217/pmt-2022-0085. Epub 2023 May 15. Pain Manag. 2023. PMID: 37183454 Free article. Review.

2

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia.

Philipp CS, Faiz A, Heit JA, Kouides PA, Lukes A, Stein SF, Byams V, Miller CH, Kulkarni R. Philipp CS, et al. Am J Obstet Gynecol. 2011 Mar;204(3):209.e1-7. doi: 10.1016/j.ajog.2010.10.897. Epub 2011 Jan 17. Am J Obstet Gynecol. 2011. PMID: 21247551 Free PMC article.

3

Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: clinical outcomes in the medicine or surgery trial.

Lukes AS, Kouides PA. Lukes AS, et al. Obstet Gynecol. 2004 Oct;104(4):864; author reply 864-5. doi: 10.1097/01.AOG.0000139831.25283.50. Obstet Gynecol. 2004. PMID: 15458911 No abstract available.

4

A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding.

Freeman EW, Lukes A, VanDrie D, Mabey RG, Gersten J, Adomako TL. Freeman EW, et al. Am J Obstet Gynecol. 2011 Oct;205(4):319.e1-7. doi: 10.1016/j.ajog.2011.05.015. Epub 2011 May 14. Am J Obstet Gynecol. 2011. PMID: 21777897 Clinical Trial.

5

The risk of stroke and death in patients with aortic and mitral valve endocarditis.

Cabell CH, Pond KK, Peterson GE, Durack DT, Corey GR, Anderson DJ, Ryan T, Lukes AS, Sexton DJ. Cabell CH, et al. Among authors: lukes as. Am Heart J. 2001 Jul;142(1):75-80. doi: 10.1067/mhj.2001.115790. Am Heart J. 2001. PMID: 11431660

6

A benefit-risk review of systemic haemostatic agents: part 1: in major surgery.

Fraser IS, Porte RJ, Kouides PA, Lukes AS. Fraser IS, et al. Among authors: lukes as. Drug Saf. 2008;31(3):217-30. doi: 10.2165/00002018-200831030-00003. Drug Saf. 2008. PMID: 18302446 Review.

7

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid.

Kouides PA, Byams VR, Philipp CS, Stein SF, Heit JA, Lukes AS, Skerrette NI, Dowling NF, Evatt BL, Miller CH, Owens S, Kulkarni R. Kouides PA, et al. Among authors: lukes as. Br J Haematol. 2009 Apr;145(2):212-20. doi: 10.1111/j.1365-2141.2009.07610.x. Epub 2009 Feb 19. Br J Haematol. 2009. PMID: 19236375 Free article. Clinical Trial.

8

The spectrum of haemostatic characteristics of women with unexplained menorrhagia.

Miller CH, Philipp CS, Stein SF, Kouides PA, Lukes AS, Heit JA, Byams VR, Dowling NF, Kulkarni R. Miller CH, et al. Among authors: lukes as. Haemophilia. 2011 Jan;17(1):e223-9. doi: 10.1111/j.1365-2516.2010.02382.x. Epub 2010 Oct 6. Haemophilia. 2011. PMID: 21040234

9

Management of excessive menstrual bleeding in women with hemostatic disorders.

Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Kadir RA, et al. Among authors: lukes as. Fertil Steril. 2005 Nov;84(5):1352-9. doi: 10.1016/j.fertnstert.2005.04.062. Fertil Steril. 2005. PMID: 16275229 Review.

10

A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding.

Fraser IS, Porte RJ, Kouides PA, Lukes AS. Fraser IS, et al. Among authors: lukes as. Drug Saf. 2008;31(4):275-82. doi: 10.2165/00002018-200831040-00001. Drug Saf. 2008. PMID: 18366238 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page